Account
Havas Media bags digital duties of Piramal Enterprises’ consumer products division
MUMBAI: Havas Media has bagged the digital duties of Piramal Enterprises Ltd's (PEL) Consumer Products Division. PEL is one of India's large diversified companies with presence in Pharma, Financial Services and Healthcare Information Management. The pitch was jointly won along with Havas Group’s healthcare specialists, Havas Life Sorento.
The mandate includes social media, content, ORM, SEO and website duties for PEL’s Consumer Products Division comprising of 22 brands across categories such as skin care, vitamins & nutrition, antacids, analgesics, gastro-intestinal, and baby-care. The account will be handled out of the agency’s Mumbai office.
Piramal Group is a global business conglomerate with diverse interests in Pharma, Financial Services, Healthcare Information Management, Real Estate and Glass Packaging. The Group has offices in over 30 countries and a global brand presence in more than 100 markets.
PEL’s Consumer Products Division caters to the Indian self-care market, and is one of the fastest growing businesses of the company, and is currently one of the leading companies in the OTC segment with top brands such as Saridon, Supradyn, Lacto Calamine, i-pill, i-know, Polycrol, Tetmosol, and Caladryl.
Havas Media Group, India managing director Mohit Joshi said, “We are delighted to be partnering with a renowned meaningful brand like Piramal that caters to the Indian self-care market with a purpose to improve people's lives by offering products that address their routine-disruptors. Havas with its combined capabilities from creative, media and healthcare divisions, manifested in our ‘Village’ Together model, will aim to provide the best consumer-centric solutions to the client. Based on the philosophy of 'Doing Well and Doing Good', Piramal Group is known to create long-term value for its stakeholders and the community at large, and we are delighted to be their trusted torchbearers in this journey.”
MUMBAI: BigTrunk Communications, an integrated digital marketing agency known for driving brand transformations across industries, has been awarded the digital marketing mandate for Soframycin, one of India’s most trusted antiseptic cream brands from the EncubeEthicals portfolio. With this collaboration, Soframycin makes its debut into the digital space, aiming to amplify its presence across India through compelling social media narratives and data-led campaigns. BigTrunk will lead the brand’s digital strategy and execution, with a focus on connecting Soframycin’s legacy of trust with today’s health-conscious and digitally engaged audience.
Soframycin has been a household name for generations, widely recognized for its efficacy in treating cuts, burns, and wounds. Backed by the scientific rigor and pharmaceutical expertise of EncubeEthicals, a pharmaceutical powerhouse since 1998, the brand benefits from the expertise of over 1,400 professionals, including more than 200 R&D specialists and a robust team of quality experts. With a presence in over 50 countries, Encube’s commitment to excellence in topical formulations adds deep credibility to Soframycin’s legacy. Now, as the brand enters the digital space, BigTrunk Communications will lead the charge in reimagining Soframycin’s story—creating modern, relatable digital experiences that stay true to its heritage.
“As we take Soframycin into its next chapter of growth, embracing digital media is not just a strategy but a necessity. We wanted a partner who could translate our scientific credibility into engaging, relatable content for today’s audience,” said Soframycin vice president – marketing, Ajay Rawal. “BigTrunk’s deep understanding of healthcare communications and digital behavior makes them the ideal partner to build meaningful narratives around wound care, trust, and wellbeing.”
“Soframycin is more than a product—it’s a legacy deeply rooted in care and science,” added BigTrunk Communications founder & managing director Bharat Subramaniam. “We’re excited to take on this responsibility of guiding a heritage brand into the digital world. Our focus will be on creating contextual storytelling and purpose-driven campaigns that bring Soframycin closer to Indian families, both old and new.”
